EP 1220900 A2 20020710 - GENE TRANSFER VECTORS FOR TREATING AUTOIMMUNE DISEASES AND DISEASES WITH IMMUNOPATHOGENESIS BY THERAPY
Title (en)
GENE TRANSFER VECTORS FOR TREATING AUTOIMMUNE DISEASES AND DISEASES WITH IMMUNOPATHOGENESIS BY THERAPY
Title (de)
GENTRANSFERVEKTOREN ZUR THERAPIE VON AUTOIMMUNERKRANKUNGEN UND ERKRANKUNGEN MIT IMMUNPATHOGENESE
Title (fr)
VECTEUR DE TRANSFERT DE GENES DESTINE A LA THERAPIE DE MALADIES AUTO-IMMUNES ET DE MALADIES AVEC IMMUNOPATHOGENIE
Publication
Application
Priority
- DE 0003608 W 20001012
- DE 19948983 A 19991012
Abstract (en)
[origin: WO0127254A2] The invention relates to a gene transfer vector, comprising at least one nucleic acid molecule comprising a first nucleic acid sequence which codes for one or more ligands that trigger apoptosis, a second nucleic acid sequence which codes for one or more antigens, optionally, a third nucleic acid sequence which codes for one or more anti-apoptosis molecules, and optionally, a fourth nucleic acid sequence which codes for one or more suicide enzymes.
IPC 1-7
IPC 8 full level
A61K 39/00 (2006.01); C12N 15/09 (2006.01); A61K 35/74 (2015.01); A61K 35/76 (2015.01); A61K 35/761 (2015.01); A61K 35/763 (2015.01); A61K 48/00 (2006.01); A61P 1/00 (2006.01); A61P 1/04 (2006.01); A61P 1/12 (2006.01); A61P 1/16 (2006.01); A61P 3/10 (2006.01); A61P 5/14 (2006.01); A61P 5/38 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 17/14 (2006.01); A61P 19/02 (2006.01); A61P 21/00 (2006.01); A61P 21/04 (2006.01); A61P 25/00 (2006.01); A61P 29/00 (2006.01); A61P 37/00 (2006.01); A61P 37/02 (2006.01); A61P 37/06 (2006.01); C07K 14/705 (2006.01); C12N 15/00 (2006.01); C12N 15/85 (2006.01)
CPC (source: EP US)
A61K 39/0008 (2013.01 - EP); A61K 48/0058 (2013.01 - EP); A61P 1/00 (2018.01 - EP); A61P 1/04 (2018.01 - EP); A61P 1/12 (2018.01 - EP); A61P 1/16 (2018.01 - EP); A61P 3/10 (2018.01 - EP); A61P 5/14 (2018.01 - EP); A61P 5/38 (2018.01 - EP); A61P 17/00 (2018.01 - EP); A61P 17/06 (2018.01 - EP); A61P 17/14 (2018.01 - EP); A61P 19/02 (2018.01 - EP); A61P 21/00 (2018.01 - EP); A61P 21/04 (2018.01 - EP); A61P 25/00 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 37/00 (2018.01 - EP); A61P 37/02 (2018.01 - EP); A61P 37/06 (2018.01 - EP); C07K 14/70575 (2013.01 - EP); C12N 15/85 (2013.01 - EP); A61K 39/00 (2013.01 - EP US); A61K 48/00 (2013.01 - EP); A61K 2035/124 (2013.01 - EP); C12N 2800/40 (2013.01 - EP); C12N 2840/203 (2013.01 - EP); Y02A 50/30 (2018.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated extension state (EPC)
AL LT LV MK RO SI
DOCDB simple family (publication)
WO 0127254 A2 20010419; WO 0127254 A3 20020228; AU 2147901 A 20010423; AU 782255 B2 20050714; CA 2387146 A1 20010419; DE 10083095 D2 20020131; EP 1220900 A2 20020710; IL 148805 A0 20020912; JP 2003513619 A 20030415
DOCDB simple family (application)
DE 0003608 W 20001012; AU 2147901 A 20001012; CA 2387146 A 20001012; DE 10083095 T 20001012; EP 00984828 A 20001012; IL 14880500 A 20001012; JP 2001530459 A 20001012